摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-3-(2,6-dichlorophenyl)acrylaldehyde | 99668-08-3

中文名称
——
中文别名
——
英文名称
(E)-3-(2,6-dichlorophenyl)acrylaldehyde
英文别名
2,6-dichloro-trans-cinnamaldehyde;2,6-dichlorocinnamaldehyde;2.6-dichlorocinnamaldehyde;3-(2,6-Dichlorophenyl)prop-2-enal;(E)-3-(2,6-dichlorophenyl)prop-2-enal
(E)-3-(2,6-dichlorophenyl)acrylaldehyde化学式
CAS
99668-08-3
化学式
C9H6Cl2O
mdl
——
分子量
201.052
InChiKey
WHDVOHFECBHCJF-NSCUHMNNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    50-55 °C
  • 沸点:
    126-131 °C(Press: 1 Torr)
  • 密度:
    1.325±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Enantioselective Cu-Catalyzed Nucleophilic Addition of Fluorinated Reagents: C–C Bond Formation for the Synthesis of Chiral Vicinal Difluorides
    作者:Huaxin Lin、Wei Jiao、Zhiwei Chen、Jian Han、Dongmei Fang、Min Wang、Jian Liao
    DOI:10.1021/acs.orglett.2c00518
    日期:2022.3.25
    Cu/sulfoxide phosphine (SOP) complex catalyzed nucleophilic addition of fluorinated enolates to gem-difluoroalkenes. The enantioenriched vicinal difluorides, containing a chiral tertiary fluoride and a fluoroalkene, were successfully afforded via C–C bond formation in good yields (up to 94% yield), high Z/E-selectivity (5:1 → 50:1 for Z-isomer), and excellent enantioselectivities (up to 98.5:1.5 er). Utility
    在这里,我们描述了第一个对映选择性 Cu/亚砜膦 (SOP) 配合物催化化烯醇化物与偕二烯烃的亲核加成。含有手性叔化物和代烯烃的对映体富集的连二化物通过 C-C 键的形成成功地提供了良好的产率(高达 94% 的产率),高Z / E选择性(5:1 → 50:1 for Z -异构体)和出色的对映选择性(高达 98.5:1.5 er)。通过对复杂的生物活性化合物的修饰证明了这种方法的实用性。
  • Organocatalytic Asymmetric Michael-Hemiacetalization Reaction Between 2-Hydroxyacetophenones and Enals: A Route to Chiral β,γ-Disubstituted γ-Butyrolactones
    作者:Megha Balha、Buddhadeb Mondal、Subas Chandra Sahoo、Subhas Chandra Pan
    DOI:10.1021/acs.joc.7b00363
    日期:2017.6.16
    The first highly enantioselective organocatalytic reaction employing 2-hydroxyacetophenones is disclosed, namely Michael-hemiacetalization reaction of 2-hydroxyacetophenones with enals. The combination of a primary amine and a secondary amine catalyst was found to be the best choice for this methodology. The products of this reaction were obtained in high enantio- and diastereoselectivities and were
    公开了使用2-羟基苯乙酮的第一个高对映选择性有机催化反应,即2-羟基苯乙酮与烯醛的迈克尔-半缩醛化反应。发现伯胺和仲胺催化剂的组合是该方法的最佳选择。该反应的产物以高对映体和非对映体选择性获得,并转化为多种生物学上重要的γ-丁内酯
  • Diarylprolinol‐Mediated Asymmetric Direct Cross‐Aldol Reaction of α,β‐Unsaturated Aldehyde as an Electrophilic Aldehyde
    作者:Yujiro Hayashi、Kaito Nagai、Shigenobu Umemiya
    DOI:10.1002/asia.201901236
    日期:2019.12.2
    The diarylprolinol-mediated asymmetric direct cross-aldol reaction of α,β-unsaturated aldehyde as an electrophilic aldehyde was developed. The reaction becomes accelerated by an acid when a carbonyl group is introduced at the γ-position of the α,β-unsaturated aldehyde. Synthetically useful γ,δ-unsaturated β-hydroxy aldehydes were obtained with high anti-selectivity and excellent enantioselectivity
    研制了二芳基脯醇介导的α,β-不饱和醛作为亲电子醛的不对称直接交叉羟醛缩合反应。当在α,β-不饱和醛的γ-位置引入羰基时,反应被酸加速。以高的抗选择性和优异的对映选择性获得了合成上有用的γ,δ-不饱和β-羟基醛。
  • Phenylalanine derivatives
    申请人:Sagi Kazuyuki
    公开号:US20050101779A1
    公开(公告)日:2005-05-12
    The present invention relates to the following phenylalanine derivatives or analogues thereof having an antagonistic activity to α4 integrin and therapeutic agents for various diseases concerning α4 integrin.
    本发明涉及以下苯丙酸衍生物或其类似物,具有对α4整合素的拮抗活性以及与α4整合素有关的各种疾病的治疗剂。
  • NEW PHENYLALANINE DERIVATIVES
    申请人:MAKINO Shingo
    公开号:US20120253041A1
    公开(公告)日:2012-10-04
    Specified phenylalanine derivatives and analogues thereof have an antagonistic activity to α4 integrin. They are used as therapeutic agents for various diseases concerning α4 integrin.
    指定的苯丙酸衍生物及其类似物具有对α4整合素的拮抗作用。它们被用作治疗涉及α4整合素的各种疾病的治疗剂。
查看更多